Mankind Pharma receives ratings action from ICRA
(17 Jan 2026)
Back
| Mankind Pharma announced that ICRA has assigned the rating ICRA AA+; Stable / ICRA A1+ for debt facilities of the company including non-convertible debentures. The rating on commercial paper of ICRA A1+ has been withdrawn. |